DEFTA Partners
Overview
DEFTA Partners is a venture capital firm that invests in early-stage technology companies, with a focus on innovative solutions in information technology and life sciences sectors. They seek to invest in technologies in the information technology, biotechnology, pharmaceutical, and healthcare sectors. Since the 1980s, DEFTA Partners has invested in more than 100 companies in the U.S., U.K., Israel, Bangladesh, and Japan. DEFTA's investments normally range from $500,000 to $3 million, however, the firm has the flexibility to invest outside this range, should the right opportunity present itself. DEFTA takes a hands on approach and plays an active role with its portfolio companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Endogena Therapeutics | Dec 2021 | Series A Extension | Co-investor |
| Acepodia | Dec 2021 | Series C | Co-investor |
| Acepodia | Mar 2021 | Series B | Lead |
| Kyulux | Feb 2021 | Series B Extension | - |
| Endogena Therapeutics | Jan 2021 | Series A | Lead |
Key People
Yuichi Kimura
Venture Partner
Masa Isono
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.